In these lines, a series of studies in the context of tauopathy, aging, and AD suggests that co-regulatory signaling through PD-L1 and PD-1 may improve neuropathology and associated cognitive impairments, highlighting the relevance of this checkpoint in the CNS23,45–47. The gene discussed is CD274; the disease is Cognitive impairment.